
Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
India's top court hears challenges to ruling on women's entry into temple - 2
Private sector revives the climate disaster database Trump tried to squash - 3
Christopher Nolan's 'The Odyssey' trailer: See Anne Hathaway, Matt Damon and Tom Holland in 1st look at movie - 4
Watching ‘Home Alone’ with the kids this holiday season? Brace yourself for '6-7.' - 5
A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video)
Venus shines at its best in spring and summer 2026 — here's what to look for
Heart disease risk greater for women with a common condition they may not be aware they have
Burkina Faso forces killed twice as many civilians as jihadists, rights group says
Figure out How to Stay away from Normal Handshaking Missteps
German politician urges more face-to-face interaction in digital age
Polish law aimed at lowering petrol prices takes effect on Tuesday
Abbott issues US device correction for some glucose monitors over faulty readings risk
Middle East hotels hit pandemic-era lows amid Iran war













